Clinical Trials

Search for trials
Clinical Trial
  • Status: Enrolling by invitation
  • Intervention Type: Other
  • Participants: 375
  • Start Date: March 1, 2021
Nephrotic Syndrome Study Network (NEPTUNE) Match Study
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 148
  • Start Date: July 29, 2020
Rituximab From the First Episode of Minimal Change Nephrotic Syndrome for Preventing Relapse Risk in Adult Patients: a Multicenter Randomized Controlled Trial
Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 125
  • Start Date: July 28, 2020
A Phase 2a Multiple Ascending, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GFB-887, a TRPC5 Channel Inhibitor, in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease
Clinical Trial
  • Status: Recruiting
  • Participants: 3000
  • Start Date: May 5, 2020
Global Kidney Patient Trials Network
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 260
  • Start Date: March 13, 2020
A National Prospective Cohort of Patients With Idiopathic Nephrotic Syndrome Beginning in Childhood.
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Device
  • Participants: 30
  • Start Date: December 1, 2019
Effect of Daily Transcutaneous Auricular Vagus Nerve (taVNS) Stimulation on Proteinuria in Pediatric Patients With Idiopathic Nephrotic Syndrome
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 8
  • Start Date: October 2, 2019
Precision Medicine Proof of Concept for Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 3000
  • Start Date: May 1, 2019
Multicenter Prospective Cohort of Kidney Biopsy for Glomerular Disease Research
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 40
  • Start Date: August 22, 2018
Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome Unresponsive to 8 Weeks of High Dose Prednisone
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 96
  • Start Date: May 1, 2018
Treatment of Primary Minimal Change Nephropathy: A Randomized Open-labeled Non-inferiority Study on Prednisolone and Vitamin D
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 500
  • Start Date: April 1, 2018
The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)
Clinical Trial
  • Status: Recruiting
  • Participants: 400
  • Start Date: August 3, 2014
The Canadian Childhood Nephrotic Syndrome (CHILDNEPH) Project
Showing 1-12 of 15